AGM Details

The 101st Annual General Meeting will be held on Tuesday, 30th June 2026 at 11:00 a.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The registered office at GSK House, Dr. Annie Besant Road, Worli, Mumbai 400030 shall be the deemed venue.

Ordinary Business Agenda

1. To receive, consider and adopt the Audited Financial Statements (including Consolidated Financial Statements) for the financial year ended 31st March 2026, together with Reports of Board of Directors and Auditors

2. To declare Dividend of ₹57 per share on Equity Shares for financial year ended 31st March 2026

3. To appoint Mr. Subesh Williams (DIN: 07786724) who retires by rotation and offers himself for re-appointment

Special Business Agenda

4. Commission to Independent Directors (Special Resolution)

Pursuant to Section 197 of Companies Act, 2013, seeks approval for payment of commission to non-Whole-time Directors (excluding Whole-time Directors and Directors employed in GSK Group Companies) for period from 1st April 2026 to 31st March 2031. Commission amount subject to ceiling of 1% of net profits computed under Section 198 of Companies Act, 2013, with Board authority to distribute amongst Directors.

5. Ratification of Cost Auditor Remuneration for FY2026 (Ordinary Resolution)

Ratification of remuneration payable to R. Nanabhoy & Company (Firm Registration No. 007464) for cost audit for year ending 31st March 2026: ₹8.02 Lakhs plus applicable taxes and reimbursement of out-of-pocket expenses.

6. Ratification of Cost Auditor Remuneration for FY2027 (Ordinary Resolution)

Ratification of remuneration payable to R. Nanabhoy & Company for cost audit for year ending 31st March 2027: ₹8.42 Lakhs plus applicable taxes and reimbursement of out-of-pocket expenses.

Dividend Details

  • Record Date: Friday, 29th May 2026 for determining entitlement to final dividend
  • Payment: Subject to deduction of tax at source
  • Beneficial Owners: Payment based on data from NSDL and CDSL as of close of business on 29th May 2026
  • Physical Shareholders: Payment to members as of close of business on 29th May 2026
  • All dividend payments will be made only through electronic modes approved by RBI

Unclaimed Dividend Information

Dividend declared for financial year ended 31st March 2019 (unclaimed) will be transferred to Investor Education and Protection Fund (IEPF). Members must claim dividends before due dates:

| Financial Year | Dividend Declaration Date | Rate per Share (₹) | Due Date for Transfer to IEPF |

| 2018-2019 | 23/July/2019 | 20 | 27th August 2026 |

| 2019-2020 | 27/July/2020 | 40 | 1st September 2027 |

| 2020-2021 | 27/July/2021 | 30 | 31st August 2028 |

| 2021-2022 | 26/July/2022 | 90 | 31st August 2029 |

| 2022-2023 | 26/July/2023 | 32 | 31st August 2030 |

| 2023-2024 | 28/June/2024 | 32 | 6th August 2031 |

| 2024-2025 | 12/November/2024 | 12 | 18th December 2031 |

| 2024-2025 | 27/June/2025 | 42 | 5th August 2032 |

E-Voting Arrangements

  • Remote e-voting period: 9:00 a.m. on Friday, 26th June 2026 to 5:00 p.m. on Monday, 29th June 2026
  • Cut-off date for voting rights: Tuesday, 23rd June 2026
  • Scrutinizer: Mr. P. N. Parikh (FCS 327), failing him Ms. Jigyasa N. Ved (FCS 6488), failing her Mr. Mitesh Dhabliwala (FCS 8331) of Parikh & Associates
  • Results will be declared at Registered Office and placed on company website (www.gsk-india.com) and NSDL website (www.evoting.nsdl.com)

Shareholder Information

  • Registrar & Share Transfer Agent: KFin Technologies Limited
  • Members must register/update email addresses for electronic communication
  • SEBI has mandated securities be held in dematerialized form only
  • Special time-bound window for dematerialization of physical securities: 5th February 2026 to 4th February 2027
  • PAN submission mandatory for all shareholders
  • Dividend income taxable in hands of members w.e.f. 1st April 2020 with TDS deduction

Explanatory Statement Details

Item 4: Commission to Directors

Previous approval for commission payment was valid from 1st April 2021 to 31st March 2026. Fresh approval sought for period 1st April 2026 to 31st March 2031. Directors interested: Ms. R. S. Karnad, Mr. M. Anand, Mr. Somasundaram P.R., Dr. A. Wadhawan and Dr. (Ms.) S. Maheshwari.

Items 5 & 6: Cost Auditor Remuneration

Board of Directors approved appointment of R. Nanabhoy & Company based on Audit Committee recommendation. Remuneration requires member ratification as per Section 148(3) of Companies Act, 2013. No directors, KMPs or their relatives are concerned or interested in these resolutions.